Durect out-licenses analgesic Posimir to Irish biotech in $136M deal; Arcutis gets 9-figure loan to push for OK for psoriasis cream
California’s Durect has made a deal with a biotech located all the way across the pond — in Ireland.
The two biotechs announced a licensing deal …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
